Pages
Products

AAV9-TRE-Cre

For research use only. Not intended for any clinical use.

Cat. No. :   AAV00283Z

Serotype :   AAV Serotype 9 Storage :   -80 ℃

Titer: Size:

Inquire for Price

Virus Particles Information

Quality Control

Cat. No. AAV00283Z
Description AAV serotype 9 particles contain Cre recombinase under TRE-Tight promoter and its expression can be responsive to the tTA and rtTA regulatory proteins.
Serotype AAV Serotype 9
Titer Varies lot by lot, typically ≥1x10^12 GC/mL
Size Varies lot by lot, for example, 30 μL, 100 μL, 500 μL etc.
Storage Store at -80℃. Avoid multiple freeze/thaw cycles.
Shipping Frozen on dry ice
Summary Creative Biogene ensures high-quality AAV particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between AAV particle lots.
Endotoxin Endotoxins, primarily derived from Gram-negative bacteria, can trigger adverse immune responses. Endotoxin contamination is a significant concern in the production of AAV, especially for applications in animal studies and gene therapy. Effective endotoxin quality control is essential in the development and manufacturing of AAV particles. Creative Biogene utilizes rigorous endotoxin detection methods to monitor the endotoxin level in our produced AAV particles to ensure regulatory compliance.
Purity AAV purity is critical for ensuring the safety and efficacy of AAV-based applications.AAV capsids are composed of three main protein components, known as viral proteins: VP1, VP2, and VP3. These proteins play a critical role in the structure and functionality of the AAV capsid. Monitoring the VP1, VP2, and VP3 content in AAV preparations is essential for quality control in AAV production. Our AAV particles are tested for showing three clear bands of VP1, VP2 VP3 by SDS-PAGE.
Sterility The AAV virus samples are inoculated into the cell culture medium for about 5 days to detect bacterial and fungal growth.
Transducibility Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of AAV to deliver genetic material into target cells or tissues, and assess gene expression and functional activities.
Empty vs. Full Capsids Based-on our proprietary AAV production and purification technology, Creative Biogene can always offer AAV particles with high ratio of full capsids. If required, we can also assess the ratio for a specifc lot of AAV particles by transmission electron microscopy (TEM) or other methods.
Quick Inquiry

Background

Case Study

Q & A

Customer Reviews

AAV is a small non-enveloped virus with a diameter of 25 nm and a single-stranded DNA (ssDNA) genome of 4.7 kb. Its capsid is icosahedral in shape with T = 1 symmetry and consists of three viral proteins, VP1, VP2, and VP3, in a ratio of approximately 1:1:10, with VP3 being the most abundant protein. Despite the very limited genome size of AAV (4.7 kb), multiple open reading frames (ORFs) and alternative splicing expand its coding capacity. The AAV genome consists of two coding regions, called rep and cap, with three ORFs encoding eight viral proteins regulated by three different promoters. These promoters are called p5, p19, and p40 based on their map positions on the genome (positions 0.06, 0.19, and 0.385, respectively).

p5 and p19 promote transcription of mRNAs that produce regulatory (Rep) proteins. Full-length p5 mRNA is translated into Rep78, and its spliced mRNA is translated into Rep68. Full-length p19 mRNA is translated into Rep52, and its spliced mRNA is translated into Rep40. Starting from the p40 promoter, two spliced mRNAs use four different start codons to produce three capsid proteins (VP1, VP2, VP3) and the assembly activation protein (AAP). VP1 is translated from the minor spliced mRNA. VP2, VP3, and AAP are translated from the major spliced mRNA, where VP3 has a conventional AUG start codon and VP2 has a weak ACG start codon. AAP is translated from another weak start codon (CTG) in a different reading frame. The AAV coding sequence is flanked by two non-coding sequences, the inverted terminal repeat (ITR) sequences. Although ITRs are non-coding sequences, they are an important part of the AAV genome. ITRs self-assemble into a T-shaped double hairpin structure and provide self-priming activity for DNA replication as well as packaging signals. ITRs are the only cis-acting elements required for genome packaging and are therefore the only AAV-derived sequences required for recombinant AAV (rAAV) vectors.

Extracellular dopamine (DA) levels are limited by the presynaptic DA transporter (DAT), a major psychostimulant target. Using chemogenetics and conditional gene silencing, researchers show that activation of presynaptic Gq-coupled receptors (hM3Dq or mGlu5) drives rapid biphasic DAT membrane trafficking in isolated striatal slices, with region-specific differences between ventral and dorsal striata. DAT insertion requires D2 DA autoreceptors and intact retromers, while DAT retrieval requires PKC activation and Rit2. Ex vivo voltammetric studies revealed that DAT trafficking impacts DA clearance. Furthermore, dopaminergic mGlu5 silencing increases DAT surface expression and abolishes motor learning, which is rescued by DAT inhibition using a subthreshold CE-158 dose. Researchers find that presynaptic DAT trafficking is complex, multimodal, and region-specific, and identify for the first time a cell-autonomous mechanism controlling presynaptic DAT tone. Importantly, these findings are consistent with a role for regulated DAT trafficking in DA clearance and motor function.

Here, researchers tested whether DAergic mGlu5 is required for biphasic DAT transport. Bilateral AAV9-TRE-Cre injection into Pitx3IRES-tTA;mGlu5fl/fl mouse VTA significantly reduced midbrain mGlu5 mRNA and protein expression as compared with AAV9-TRE-enhanced GFP (eGFP)-injected controls (Figure 1A and B). DAergic mGlu5 silencing completely abolished DHPG-stimulated DAT insertion in the VS and DS (Figure 1C and D), consistent with the premise that mGlu5 is expressed presynaptically in DA terminals, where it stimulates DAT trafficking in a cellautonomous manner. The researchers further hypothesized that DAT surface tone in the striatum is a balance between DRD2-stimulated DAT insertion and mGlu5-mediated retrieval, and therefore predicted that mGlu5 silencing in DA neurons would result in enhanced basal DAT surface expression. To test this possibility, basal DAT surface levels were measured after conditional mGlu5 silencing. DAergic mGlu5 loss significantly increased baseline DAT surface levels in VS and DS compared with slices from control mice (Figure 1E), indicating that mGlu5-stimulated DAT retrieval significantly affects striatal DAT surface tone.

mGlu5-mediated DAT trafficking is mediated presynaptically and impacts basal DAT surface expression.Figure 1. mGlu5-mediated DAT trafficking is mediated presynaptically and impacts basal DAT surface expression. (Kearney P J, et al., 2023)

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Timely delivery

The delivery process was remarkably smooth and quick. We received our order earlier than expected, which allowed us to start our project ahead of schedule. The packaging was secure, ensuring that the product arrived in perfect condition.

French

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction